Elevate Your Investing Strategy:
- Supercharge your investment decisions! Grab TipRanks Premium at a 55% Discount! Get access to powerful tools, in-depth data analysis, and expert financial advice to help you invest with more confidence.
Here’s the latest on Helius Medical Technologies ( (HSDT) ).
As of September 29, 2025, Helius Medical Technologies has officially changed its corporate name to Solana Company, a move emphasizing its focus on the Solana blockchain network. The company has also signed a preliminary, non-binding agreement with the Solana Foundation, which details potential areas of collaboration and options to purchase SOL digital currency. This strategic shift illustrates Solana Company’s commitment to becoming a significant player in the blockchain space, utilizing its treasury to acquire SOL tokens and contribute to the Solana ecosystem’s growth.
The most recent analyst opinion on (HSDT) stock suggests a Hold rating with a target price of $15.50. For a comprehensive overview of analyst predictions concerning Helius Medical Technologies, consult the HSDT Stock Forecast page.
Spark’s Viewpoint on HSDT Stock
Spark, TipRanks’ AI Analyst, currently rates HSDT as Neutral.
Helius Medical Technologies is currently grappling with substantial financial headwinds, primarily characterized by decreasing revenue and a lack of profitability. While certain technical indicators suggest emerging positive momentum, the company’s valuation remains unattractive due to persistent losses. The overall assessment underscores the company’s urgent need to bolster its financial standing and improve its operational efficiency.
To view Spark’s complete analysis of HSDT stock, click here.
More Information About Helius Medical Technologies
Helius Medical Technologies, Inc., now Solana Company, is a prominent neurotechnology innovator in the medical device sector. They specialize in addressing neurological impairments by utilizing an orally-applied technology platform. Their flagship product, the Portable Neuromodulation Stimulator (PoNS), is designed to promote neuroplasticity and improve the quality of life for individuals living with neurological disorders.
Average Daily Trading Volume: 790,066
Technical Sentiment Indicator: Strong Sell
Current Market Capitalization: $14.65M
Explore further insights into HSDT stock on TipRanks’ Stock Analysis page.